BIO-TECHNE CORP (TECH) Stock Fundamental Analysis
USA - NASDAQ:TECH - US09073M1045 - Common Stock
59.38 USD
-1.37 (-2.26%)
59.38 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to TECH. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making TECH a very profitable company, without any liquidiy or solvency issues. TECH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year TECH was profitable.
TECH had a positive operating cash flow in the past year.
Each year in the past 5 years TECH has been profitable.
TECH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
TECH's Return On Assets of 3.04% is fine compared to the rest of the industry. TECH outperforms 74.14% of its industry peers.
TECH has a better Return On Equity (3.91%) than 74.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, TECH belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 13.56%.
The last Return On Invested Capital (9.33%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROIC | 9.33% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
Looking at the Profit Margin, with a value of 6.32%, TECH is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
TECH's Profit Margin has declined in the last couple of years.
TECH's Operating Margin of 22.13% is amongst the best of the industry. TECH outperforms 91.38% of its industry peers.
TECH's Operating Margin has been stable in the last couple of years.
TECH has a Gross Margin of 66.83%. This is amongst the best in the industry. TECH outperforms 91.38% of its industry peers.
TECH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TECH is destroying value.
TECH has less shares outstanding than it did 1 year ago.
TECH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TECH is higher compared to a year ago.
2.2 Solvency
TECH has an Altman-Z score of 11.55. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
TECH has a better Altman-Z score (11.55) than 94.83% of its industry peers.
The Debt to FCF ratio of TECH is 1.34, which is an excellent value as it means it would take TECH, only 1.34 years of fcf income to pay off all of its debts.
TECH has a Debt to FCF ratio of 1.34. This is amongst the best in the industry. TECH outperforms 89.66% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that TECH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, TECH is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Altman-Z | 11.55 |
ROIC/WACC0.91
WACC10.22%
2.3 Liquidity
A Current Ratio of 4.22 indicates that TECH has no problem at all paying its short term obligations.
TECH has a better Current ratio (4.22) than 65.52% of its industry peers.
A Quick Ratio of 2.81 indicates that TECH has no problem at all paying its short term obligations.
TECH has a Quick ratio of 2.81. This is in the better half of the industry: TECH outperforms 60.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 |
3. Growth
3.1 Past
TECH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
The Revenue for TECH has decreased by -16.00% in the past year. This is quite bad
TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
3.2 Future
TECH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.61% yearly.
Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 30.77, TECH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 65.52% of the companies listed in the same industry.
TECH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.96 indicates a quite expensive valuation of TECH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 75.86% of the companies listed in the same industry.
TECH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.77 | ||
| Fwd PE | 25.96 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 65.52% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TECH is valued a bit cheaper than the industry average as 63.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.26 | ||
| EV/EBITDA | 25.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)5.22
PEG (5Y)2.73
EPS Next 2Y8.87%
EPS Next 3Y9.27%
5. Dividend
5.1 Amount
With a yearly dividend of 0.53%, TECH is not a good candidate for dividend investing.
TECH's Dividend Yield is rather good when compared to the industry average which is at 0.48. TECH pays more dividend than 93.10% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, TECH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
5.2 History
The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
65.26% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.26%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
59.38
-1.37 (-2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.36%
Inst Owner Change7.11%
Ins Owners0.26%
Ins Owner Change4.02%
Market Cap9.24B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target67.89 (14.33%)
Short Float %4.47%
Short Ratio3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)1.36%
PT rev (3m)-0.31%
EPS NQ rev (1m)-3.83%
EPS NQ rev (3m)-6.9%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-6.23%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-3.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.77 | ||
| Fwd PE | 25.96 | ||
| P/S | 7.6 | ||
| P/FCF | 41.26 | ||
| P/OCF | 36.8 | ||
| P/B | 4.7 | ||
| P/tB | 14.52 | ||
| EV/EBITDA | 25.04 |
EPS(TTM)1.93
EY3.25%
EPS(NY)2.29
Fwd EY3.85%
FCF(TTM)1.44
FCFY2.42%
OCF(TTM)1.61
OCFY2.72%
SpS7.82
BVpS12.63
TBVpS4.09
PEG (NY)5.22
PEG (5Y)2.73
Graham Number23.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROCE | 11.3% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.93% | ||
| ROICexgc | 24.48% | ||
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% | ||
| FCFM | 18.41% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 25.63% | ||
| Cap/Sales | 2.24% | ||
| Interest Coverage | 14.5 | ||
| Cash Conversion | 66.94% | ||
| Profit Quality | 291.58% | ||
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 11.55 |
F-Score5
WACC10.22%
ROIC/WACC0.91
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year17.25%
EBIT Next 3Y11.13%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status for TECH stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
How profitable is BIO-TECHNE CORP (TECH) stock?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
How financially healthy is BIO-TECHNE CORP?
The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.89% in the next year.